Acute Coronary Syndrome (ACS)
37
6
6
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.4%
2 terminated out of 37 trials
90.5%
+4.0% vs benchmark
27%
10 trials in Phase 3/4
37%
7 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (37)
Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone
TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study
Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk
Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy
The Effect of IV Cangrelor and Oral Ticagrelor Study
Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome
RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Essential Hypotension and Allostasis Registry
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)
Implementing Precision Medicine Approaches to Guide Anti-platelet Selection
PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.
VITROS Immunodiagnostic Products hs Troponin I
OPTImal Management of Antithrombotic Agents: OPTIMA-5
Effect of Perioperative Clopidogrel Responsiveness on Ischemic Outcome in Patients With Acute Coronary Syndrome Undergoing Off-pump Coronary Artery Bypass Surgery